Q1 2024

Filed Dec 17, 2025 · 10-Q · 626 days after period end · 0001493152-25-028202

Q1 2024 · 10-Q

Revenue

$37.73K

no prior Q1 2023 on file

Net Income

-$426.93K

N/M vs Q1 2023

EPS Diluted

$0.00

— vs Q1 2023

Gross Profit$35,197—

Operating Income

Same quarter

Metric	Q1 2024	Q1 2023	Q1 2022	Q1 2021
Revenue	$37.73K	—	$13.76K	$22.02K
Net Income	-$426.93K	-$592.56K	$5.01M	-$34.02M
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR